Анотація:
A range of new and promising targeted drugs currently
under development for improved cancer therapy
were presented during the 11th International Congress
on Targeted Anticancer Therapies, Paris,
4–6 March 2013 (TAT 2013). TAT 2013 was attended
by over 500 participants from 46 countries. More than
60 plenary lectures and 70 posters, presented by leading
experts in clinical cancer research and drug development,
were devoted to dozens of emerging targeted
agents and new drug targets under development for
cancer therapy